Blue Jet Healthcare IPO is a book built issue of Rs 840.27 crores. The issue is entirely an offer for sale of 2.43 crore shares.

Blue Jet Healthcare IPO bidding started from October 25, 2023 and ended on October 27, 2023. The allotment for Blue Jet Healthcare IPO was finalized on Monday, October 30, 2023. The shares got listed on BSE, NSE on November 1, 2023.

Blue Jet Healthcare IPO price band is set at ₹329 to ₹346 per share. The minimum lot size for an application is 43 Shares. The minimum amount of investment required by retail investors is ₹14,878. The minimum lot size investment for sNII is 14 lots (602 shares), amounting to ₹208,292, and for bNII, it is 68 lots (2,924 shares), amounting to ₹1,011,704.

Kotak Mahindra Capital Company LimitedICICI Securities Limited and J.P. Morgan India Private Limited are the book running lead managers of the Blue Jet Healthcare IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Blue Jet Healthcare IPO RHP for detailed information.

Blue Jet Healthcare IPO Details

IPO Date October 25, 2023 to October 27, 2023
Listing Date November 1, 2023
Face Value ₹2 per share
Price Band ₹329 to ₹346 per share
Lot Size 43 Shares
Total Issue Size 24,285,160 shares
(aggregating up to ₹840.27 Cr)
Offer for Sale 24,285,160 shares of ₹2
(aggregating up to ₹840.27 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE
Share holding pre issue 173,465,425
Share holding post issue 173,465,425

Blue Jet Healthcare IPO Reservation

Blue Jet Healthcare IPO offers 24,285,160 shares. 4,857,032 (20.00%) to QIB, 3,642,774 (15.00%) to NII, 8,499,806 (35.00%) to RII and 7,285,548 (30.00%) to Anchor investors. 197,669 RIIs will receive minimum 43 shares and 2,017 (sNII) and 4,034 (bNII) will receive minimum 602 shares. (in case of oversubscription)

Investor Category Shares Offered Maximum Allottees 
Anchor Investor Shares Offered 7,285,548 (30.00%) NA
QIB Shares Offered 4,857,032 (20.00%) NA
NII (HNI) Shares Offered 3,642,774 (15.00%)  
  bNII > ₹10L 2,428,516 (10.00%) 4,034
  sNII < ₹10L 1,214,258 (5.00%) 2,017
Retail Shares Offered 8,499,806 (35.00%) 197,669
Total Shares Offered 24,285,160 (100%)  

Blue Jet Healthcare IPO Anchor Investors Details

Blue Jet Healthcare IPO raises Rs 252.08 crore from anchor investors. Blue Jet Healthcare IPO Anchor bid date is October 23, 2023. Blue Jet Healthcare IPO Anchor Investors list

Bid Date October 23, 2023
Shares Offered 7,285,548
Anchor Portion Size (In Cr.) 252.08
Anchor lock-in period end date for 50% shares (30 Days) December 13, 2023
Anchor lock-in period end date for remaining shares (90 Days) March 7, 2024

Blue Jet Healthcare IPO Timeline (Tentative Schedule)

Blue Jet Healthcare IPO opens on October 25, 2023, and closes on October 27, 2023.

IPO Open Date Wednesday, October 25, 2023
IPO Close Date Friday, October 27, 2023
Basis of Allotment Monday, October 30, 2023
Initiation of Refunds Tuesday, October 31, 2023
Credit of Shares to Demat Tuesday, October 31, 2023
Listing Date Wednesday, November 1, 2023
Cut-off time for UPI mandate confirmation 5 PM on October 27, 2023

Blue Jet Healthcare IPO Lot Size

Investors can bid for a minimum of 43 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 43 ₹14,878
Retail (Max) 13 559 ₹193,414
S-HNI (Min) 14 602 ₹208,292
S-HNI (Max) 67 2,881 ₹996,826
B-HNI (Min) 68 2,924 ₹1,011,704
Lot Size Calculator

Blue Jet Healthcare IPO Promoter Holding

Akshay Bansarilal Arora, Shiven Akshay Arora and Archana & Akshay Arora are the promoters of the company

Share Holding Pre Issue 100%
Share Holding Post Issue 86%

About Blue Jet Healthcare Limited

Incorporated in 1968, Blue Jet Healthcare is a pharmaceutical and healthcare ingredient and an intermediate company. Blue Jet Healthcare was the first manufacturer of saccharin and its salts (artificial sweeteners) in India. They later expanded into contrast media intermediates, which are used in CT scans and MRIs. The company mainly deals in three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients.

 Blue Jet Healthcare is a global, science-led pharmaceutical company. They are the provider of: 

  • Process development and production capabilities
  • Global regulatory support
  • Collaboration, development, and manufacturing of advanced pharmaceutical intermediates and API.

The company has three manufacturing facilities, which are situated in Shahad (Unit I), Ambernath (Unit II) and Mahad (Unit III) in the state of Maharashtra, India, with an annual installed capacity of 200.60 KL, 607.30 KL and 213.00 KL, respectively, as of June 30, 2023.

Company’s core strength lies in the following

  1. Huge manufacturing capacity of contrast media intermediates in India.
  2. The company operates in a niche market that has high entry barriers.
  3. Long-term relationships and long term contracts with multi-national customers.

 

Blue Jet Healthcare Limited Financial Information (Restated Standalone)

Blue Jet Healthcare Limited’s revenue increased by 5.98% and profit after tax (PAT) dropped by -11.88% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended 30 Jun 2023 31 Mar 2023 31 Mar 2022
Assets 903.80 862.07 713.38
Revenue 184.60 744.94 702.88
Profit After Tax 44.12 160.03 181.59
Net Worth 725.68 681.49 521.54
Reserves and Surplus 690.99 646.79 486.85
Total Borrowing      
Amount in ₹ Crore

Key Performance Indicator

Blue Jet Healthcare IPO Market Cap is Rs 6001.9 Cr and P/E (x) is 37.49.

KPI Values
P/E (x) 37.49
Post P/E (x) 34.02
Market Cap (₹ Cr.) 6001.9
ROE 26.60%
ROCE 31.91%
EPS (Rs) 9.23
RoNW 23.48%

Check Blue Jet Healthcare IPO Peer Comparison here.

Objects of the Issue (Blue Jet Healthcare IPO Objectives)

The company will not receive any proceeds from the Offer and all the Offer Proceeds will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer.

Blue Jet Healthcare IPO Review (Apply)

[Dilip Davda]  BJHL has created a niche place in the global markets for the products manufactured by it and enjoys long term relationship with marquee customers and FMCGs. It is on capacity expansion spree and hopes to improve its performance in coming years. On the basis of annualized FY24 earnings, the issue appears fully priced. Investors may park funds for the medium to long-term rewards in this long race horse. Read detail review…


Blue Jet Healthcare IPO Subscription Status (Bidding Detail)

The Blue Jet Healthcare IPO is subscribed 7.95 times on October 27, 2023 7:02:00 PM. The public issue subscribed 2.24 times in the retail category, 13.72 times in the QIB category, and 13.59 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category Subscription (times)
QIB 13.72
NII 13.59
    bNII (bids above ₹10L) 15.65
    sNII (bids below ₹10L) 9.48
Retail 2.24
Total 7.95

Total Application : 393,163 (1.99 times)

Blue Jet Healthcare IPO Listing Details

Listing Date November 1, 2023
BSE Script Code 544009
NSE Symbol BLUEJET
ISIN INE0KBH01020
Final Issue Price ₹346 per share

Pre-Open Session – NSE Pre-Open Session – BSE

Blue Jet Healthcare Limited Contact Details

Blue Jet Healthcare Limited
701, 702, 7th Floor, Bhumiraj Costarica
Sector 18, Sanpada
Navi Mumbai, Thane – 400 705
Phone: +91 (22) 4184 0550
Email: companysecretary@bluejethealthcare.com
Websitehttps://bluejethealthcare.com/

Blue Jet Healthcare IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: bluejet.ipo@linkintime.co.in
Websitehttps://linkintime.co.in/mipo/ipoallotment.html